gamma-aminobutyric acid has been researched along with Amaurosis in 4 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To use gabapentin to relieve discomfort in a painful, blind glaucomatous eye of a patient unwilling to undergo further invasive treatment." | 7.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin may relieve pain in a painful, blind, glaucomatous eye." | 7.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin is an antiepileptic used for neuropathic pain treatment." | 7.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Patient rated his pregabapentin and postgabapentin pain by a verbal descriptor scale and a numerical scale." | 7.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin provided significant pain relief (on a 0-10 scale, reduction from "8" to "0-2") at regular visits over 6 months." | 7.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin is an antiepileptic used for neuropathic pain treatment." | 5.35 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "To use gabapentin to relieve discomfort in a painful, blind glaucomatous eye of a patient unwilling to undergo further invasive treatment." | 3.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin may relieve pain in a painful, blind, glaucomatous eye." | 3.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin is an antiepileptic used for neuropathic pain treatment." | 3.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Patient rated his pregabapentin and postgabapentin pain by a verbal descriptor scale and a numerical scale." | 3.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin provided significant pain relief (on a 0-10 scale, reduction from "8" to "0-2") at regular visits over 6 months." | 3.74 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| "Gabapentin is an antiepileptic used for neuropathic pain treatment." | 1.35 | Gabapentin therapy for painful, blind glaucomatous eye: case report. ( Dimou, T; Kavalieratos, CS, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagena, H | 1 |
| Feldmann, M | 1 |
| Manahan-Vaughan, D | 1 |
| Laemle, LK | 1 |
| Hori, N | 1 |
| Strominger, NL | 1 |
| Tan, Y | 1 |
| Carpenter, DO | 1 |
| Kavalieratos, CS | 1 |
| Dimou, T | 1 |
| Nakadate, K | 1 |
| Imamura, K | 1 |
| Watanabe, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy: a Prospective, Randomized Study.[NCT00954187] | 8 participants (Actual) | Interventional | 2009-11-30 | Terminated (stopped due to PI left institution) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for gamma-aminobutyric acid and Amaurosis
| Article | Year |
|---|---|
Lifelong changes of neurotransmitter receptor expression and debilitation of hippocampal synaptic plasticity following early postnatal blindness.
Topics: Animals; Blindness; gamma-Aminobutyric Acid; Hippocampus; Mice; Mice, Inbred CBA; Neuronal Plasticit | 2022 |
Physiological and anatomical properties of the suprachiasmatic nucleus of an anophthalmic mouse.
Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anophthalmos; | 2002 |
Gabapentin therapy for painful, blind glaucomatous eye: case report.
Topics: Aged; Amines; Analgesics; Blindness; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Aci | 2008 |
Effects of monocular deprivation on the expression pattern of alpha-1 and beta-1 adrenergic receptors in the kitten visual cortex.
Topics: Age Factors; Animals; Astrocytes; Blindness; Cats; Cell Differentiation; Dendrites; gamma-Aminobutyr | 2001 |